CD34+ Cell Dose and Full Donor Chimerism at Day +100 Is Associated with Survival in Patients Who Received Reduced-Intensity Conditioning (RIC) With Fludarabine/Melphalan Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies

✍ Scribed by S.G. Holtan; W.J. Hogan; M.A. Elliott; D.A. Gastineau; T.G. Call; S.A. Ansell; D.J. Inwards; P.B. Johnston; M.Q. Lacy; I.N. Micallef; L.F. Porrata; A. Tefferi; M.R. Litzow

• Book ID: 116280820
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 62 KB
• Volume: 15
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2008.12.319